Shopping Cart
- Remove All
- Your shopping cart is currently empty
6β-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions. 6β-PGI1 has a much longer half-life than PGI2, but a greatly reduced molar potency for receptor mediated function. 6β-PGI1 has a Kact for adenylate cyclase in NCB-20 cells of 4.2 μM compared with 18 nM for PGI2. The potency for vasodilation and inhibition of platelet aggregation is about 1% of PGI2.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | 35 days | |
5 mg | Inquiry | 35 days | |
10 mg | Inquiry | 35 days |
Description | 6β-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions. 6β-PGI1 has a much longer half-life than PGI2, but a greatly reduced molar potency for receptor mediated function. 6β-PGI1 has a Kact for adenylate cyclase in NCB-20 cells of 4.2 μM compared with 18 nM for PGI2. The potency for vasodilation and inhibition of platelet aggregation is about 1% of PGI2. |
Alias | 6β-Prostaglandin I1 |
Molecular Weight | 354.487 |
Formula | C20H34O5 |
Cas No. | 62770-50-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMF: >10 (from 6b-PGI1), Sonication is recommended. DMSO: >5 (from 6b-PGI1), Sonication is recommended. PBS (pH 7.2): >80 μg (from 6b-PGI1), Sonication is recommended. Ethanol: >20 mg/mL (from 6b-PGI1), Sonication is recommended. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.